Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis.
Automated multi-objective calibration of biological agent-based simulations.
Arthropathy-related pain in a patient with congenital impairment of pain sensation due to hereditary sensory and autonomic neuropathy type II with a rare mutation in the WNK1/HSN2 gene: a case report.
The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' Experiences.
Pathogenesis of axonal and neuronal damage in multiple sclerosis.
The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis.
Managing the Quality of Life in Patients with Multiple Sclerosis: A Literature Review.
Protective effects of BMP-7 against tumor necrosis factor α-induced oligodendrocyte apoptosis.
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis.
Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders.
Sodium Benzoate, a Food Additive and a Metabolite of Cinnamon, Enriches Regulatory T Cells via STAT6-Mediated Upregulation of TGF-β.
Substrate reduction therapy for Krabbe's disease.
Evaluation of the benefits of treatment with TENS for neurological lower urinary tract dysfunctions.
Utility of a Multiparametric Quantitative MRI Model That Assesses Myelin and Edema for Evaluating Plaques, Periplaque White Matter, and Normal-Appearing White Matter in Patients with Multiple Sclerosis: A Feasibility Study.
An idiopathic thrombocytopenic purpura with polyneuropathy.
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study.
Commentary on painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder.
On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping.
Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
Predictors of Response to Multiple Sclerosis Therapeutics in Individual Patients.
Corpus callosum microstructural changes associated with Kawashima Nintendo Brain Training in patients with multiple sclerosis.
Lymphoid chemokines in the CNS.
Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature.
CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation.
Pages
« first
‹ previous
…
815
816
817
818
819
820
821
822
823
…
next ›
last »